Search Title

Hai Phong explores an HPV testing co-payment model for cervical cancer screening

Hai Phong explores an HPV testing co-payment model for cervical cancer screening

A co-payment model developed with local partners offers a practical pathway to bring cervical cancer screening closer to women — and support future national scale-up.

In Hai Phong, Viet Nam, a new proposed approach to HPV DNA testing is showing how cervical cancer screening can become more accessible, affordable and sustainable – by strengthening the primary healthcare systems close to women, and co-payment of the service.

Cervical cancer remains one of the most preventable yet persistent threats to women’s health. HPV DNA testing can identify women at higher risk before cancer develops, but routine access to screening remains limited in many settings because preventive services are not yet fully covered by social health insurance, there is often limited access at high level health facilities, and out-of-pocket costs can discourage participation.

To help address these barriers, FIND has been working with the Hai Phong Department of Health, the Hai Phong Center for Disease Control and primary healthcare facilities to develop a co-payment model for HPV DNA testing. The model builds on an earlier community-based pilot in which health stations collected samples while the provincial CDC provided centralized, quality-assured laboratory testing.

The pilot screened approximately 5,000 women and identified a high-risk HPV positivity rate of 8.1% consistent with the data reported by the ICO/IARC Information Centre on HPV and Cancer for Viet Nam, demonstrating both operational feasibility and the high potential to detect women at risk. This was supported by centralized testing and digitally coordinated referral, both feasible and acceptable to women and health workers. It also showed the value of using existing primary healthcare infrastructure so that screening can be offered closer to home and integrated into routine community health activities.

The co-payment model takes the implementation experience a step further. Developed using local cost data, scientific evidence and stakeholder consultation, it provides Hai Phong with a practical interim financing pathway while national discussions continue on the inclusion of preventive screening within the Social Health Insurance benefit package.

50%

maximum proposed individual co-payment

approximately VND 238,500 per test

6.78–8.01x

estimated socioeconomic return per VND invested

depending on screening scenario

30–65

age range considered for broad screening

with a focused 30–49 option where resources are constrained

*These figures are based on model assumptions and should be interpreted accordingly.

How the model works

The model connects commune and ward health stations with the provincial CDC through a digital coordination system of sample referral and transport, laboratory testing and results reporting. Women can access services near their communities, while the health system maintains testing quality, data visibility and continuity of care.

Financing is shared between local government and service users. At present, the cost of an HPV DNA test for treatment purposes in Viet Nam, ranges from approximately VND 750,000 (~US$ 29) to VND 1,250,000 (~US$ 58), while the cost estimated for this model is VND 477,000 (~US$ 18). Individual contribution could range from 21% to 50%, or approximately VND 238,500 (~US$ 9) depending on the population group and scale of implementation.

While costs are shared, priority financial support for poor households, social assistance beneficiaries, and other vulnerable groups are ensured, thereby promoting equitable access. Hai Phong can choose between broader screening for women aged 30–65 or a focused approach for women aged 30–49, who are at the highest risk, depending on available resources and implementation readiness.

The model also recognizes that affordability alone is not enough. Community advocacy and communication are central to implementation, drawing on trusted networks such as health workers, population collaborators, local Women’s Unions and Labour Unions to ensure women understand the value of screening and feel confident using the service.


Community-based screening models can make HPV DNA testing easier to access by bringing sample collection closer to where women live.

A roadmap for the future

By combining decentralized sample collection, centralized laboratory testing and shared financing, the Hai Phong model offers a pragmatic bridge between today’s financing gaps and a future in which preventive screening is more fully integrated into national health coverage.

The potential benefits are significant. Depending on the scale of implementation, HPV DNA screening could help prevent hundreds of cervical cancer cases and deaths over the next decade for the locality, while reducing treatment costs and preserving healthy life years. In economic terms, every VND invested is estimated to generate VND 6.78 to VND 8.01 in benefits.

For FIND and partners, the experience in Hai Phong provides more than a local implementation model. It offers real-world evidence that can inform policy discussions, strengthen sustainable financing mechanisms and support the gradual scale-up of accessible HPV DNA testing across Viet Nam.